IP vs PRME · P/E 43, $26.62B cap vs rev $3.0M
International Paper (IP) versus Prime Medicine, Inc. Common Stock (PRME) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
IP does not have a complete income-statement cache yet.
Latest reported PRME revenue for 2024-12-31 was $3.0M. Net income was -$195.9M. PRME currently screens at market cap $570.8M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. PRME currently screens at market cap $570.8M.
Not investment advice. Open the IP and PRME stock pages for the full models.
Not investment advice.